Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines
- 28 July 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 367 (3) , 349-354
- https://doi.org/10.1016/j.neulet.2004.06.065
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate–putamenEuropean Journal of Pharmacology, 2004
- Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's diseaseEuropean Journal of Neuroscience, 2003
- Increased Morphological Diversity of Microglia in the Activated Hypothalamic Supraoptic NucleusJournal of Neuroscience, 2003
- Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosisThe FASEB Journal, 2003
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2001
- Immune function of microgliaGlia, 2001
- Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatmentBrain Research Reviews, 2001
- Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-amphetamineBrain Research, 2000
- Microglial Reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Induced Parkinson's Disease Mice ModelNeurodegeneration, 1996
- Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat?Brain Research Bulletin, 1994